Cargando…
Targeting circular RNA-Glra2 alleviates retinal neurodegeneration induced by ocular hypertension
Glaucoma is a leading cause of irreversible vision loss characterized by retinal neurodegeneration. Circular RNAs (circRNAs) have emerged as the potential biomarkers and therapeutic targets for neurodegenerative diseases. However, the expression profiling of circRNAs in glaucomatous neurodegeneratio...
Autores principales: | Wang, Ting, Li, Shuyan, Li, Xiu-Miao, Li, Chaopeng, Wang, Fang, Jiang, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599745/ https://www.ncbi.nlm.nih.gov/pubmed/37819813 http://dx.doi.org/10.18632/aging.205108 |
Ejemplares similares
-
Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
por: Wang, Jia-Jian, et al.
Publicado: (2018) -
Excessive Startle with Novel GLRA1 Mutations in 4 Chinese Patients and a Literature Review of GLRA1-Related Hyperekplexia
por: Zhan, Feixia, et al.
Publicado: (2020) -
Circular RNA-ZNF609 regulates retinal neurodegeneration by acting as miR-615 sponge
por: Wang, Jia-Jian, et al.
Publicado: (2018) -
Neuronal Epac1 mediates retinal neurodegeneration in mouse models of ocular hypertension
por: Liu, Wei, et al.
Publicado: (2020) -
Engineering CRISPR immune systems conferring GLRaV-3 resistance in grapevine
por: Jiao, Bolei, et al.
Publicado: (2022)